BIOMAT Database Logo BIOMAT Database Logo

First-trimester alpha-fetoprotein screening for Down syndrome. 1993

W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
Institut für Humangenetik, Universität Giessen, Germany.

Screening for Down syndrome and other chromosomal aneuploidies by biochemical parameters in maternal serum is well established for the second trimester. With screening as late as 16 weeks of gestation, the option of chorionic villus sampling (CVS) unfortunately is lost. In our study population, the maternal serum alpha-fetoprotein (MSAFP) concentration was determined in 2471 women in the first trimester immediately prior to CVS. Although in this sample MSAFP tended to be lower in Down syndrome (DS) pregnancies than in pregnancies with a chromosomally normal fetus, at this early gestational age neither a fixed cut-off level of 0.5 multiples of the normal median (MOM) nor one of 0.6 MOM was suitable for identifying pregnancies at higher risk for DS. This also applied to trisomy 18, although on average MSAFP in trisomy 18 pregnancies was lower than in normal and DS pregnancies.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002887 Chromosomes, Human, Pair 18 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 18
D002888 Chromosomes, Human, Pair 19 A specific pair of GROUP F CHROMOSOMES of the human chromosome classification. Chromosome 19
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease

Related Publications

W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service.
July 2015, Prenatal diagnosis,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester screening for trisomy 21 using alpha-fetoprotein.
January 2011, Fetal diagnosis and therapy,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester Down syndrome screening.
January 2006, Clinical chemistry,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester Down syndrome screening.
December 2000, American journal of obstetrics and gynecology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester biochemical screening for Down syndrome.
June 2001, Clinics in perinatology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester sonographic screening for Down syndrome.
May 2004, Obstetrics and gynecology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester sonographic screening for Down syndrome.
May 2004, Obstetrics and gynecology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester sonographic screening for Down syndrome.
November 2003, Obstetrics and gynecology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
November 1988, American journal of obstetrics and gynecology,
W Fuhrmann, and K Altland, and V Jovanovic, and W Holzgreve, and P Miny, and D Wenger, and R Rauskolb
First-trimester screening for neural tube defects using alpha-fetoprotein.
January 2012, Fetal diagnosis and therapy,
Copied contents to your clipboard!